HER2+ metastatic breast cancer maintenance treatment
TUKYSA® (tucatinib) is a prescription medicine used in adults in combination with the medicines trastuzumab and pertuzumab for maintenance treatment of a type of breast cancer called human epidermal growth factor receptor-2 (HER2)-positive breast cancer that has spread to nearby tissue or lymph nodes and cannot be removed by surgery (unresectable locally advanced) or to other parts of the body (metastatic).
Your healthcare provider will perform a test to make sure TUKYSA is right for you.
It is not known if TUKYSA is safe and effective in children.
HER2+ metastatic breast cancer after 1 or more anti-HER2 breast cancer treatments
TUKYSA® (tucatinib) is a prescription medicine used in adults in combination with trastuzumab and capecitabine to treat human epidermal growth factor receptor-2 (HER2)-positive breast cancer that has spread to other parts of the body (metastatic), or cannot be removed by surgery, who have received 1 or more anti-HER2 metastatic breast cancer treatments.
Your healthcare provider will perform a test to make sure TUKYSA is right for you.
It is not known if TUKYSA is safe and effective in children.